<DOC>
	<DOCNO>NCT01093391</DOCNO>
	<brief_summary>The objective study evaluate security issue efficacy coronary stenting Cobalt Chrome cover sirolimus-eluting Cobalt Chrome platform patient coronary artery lesion .</brief_summary>
	<brief_title>A Trial Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus</brief_title>
	<detailed_description>Patients treat compliance eligibility criterion , stent study 16-19mm . All patient clinically follow 60 month procedure undergo control angiography 6 month . Can treat multiple lesion , measure 2.5-3.5mm ( visual estimate ) . Patients enrol randomized 1:2 propose one group without stent coating , respectively . And randomize clinical trial , prospective study 5 center include 60 patient .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>1 . Age ≥18 year ≤75 year ; 2 . Symptomatic cardiac ischemic disease and/or document evidence myocardial ischemia ; 3 . Types B1 B2 coronary lesion ( accord ACC/AHA classification modify Ellis ) ; 4 . Target lesion locate native coronary artery ; 5 . Target lesion vessel diameter range 2.5 3.5 mm ( visual estimate ) amenable treatment ( coverage ) 16 19mmlong stent ; 6 . Target lesion &gt; 50 % diameter stenosis ( visual estimate ) ; 7 . Acceptable candidate myocardial revascularization surgery ( coronary artery bypass graft surgery ) ; 8 . The subject fully inform nature study , willing comply study requirement provide write informed consent approve Ethics Committee respective clinical site . 1 . Female patient childbearing potential ; 2 . Recent Qwave myocardial infarction occur within 48 hour prior index procedure . Recent Qwave nonQwave myocardial infarction still elevate level cardiac marker ; 3 . Documented leave ventricular ejection fraction &lt; 30 % ; 4 . Renal dysfunction ( creatinine &gt; 2.0 mg/dL 177 µmol/L ) ; 5 . Platelet count &lt; 100,000 cells/mm³ &gt; 700,000 cells/mm³ . ; 6 . White blood cell count &lt; 3,000 cells/mm3 ; 7 . Suspected documented hepatic disease ( include laboratorial evidence hepatitis ) ; 8 . Heart transplant receptor ; 9 . Known hypersensitivity cobaltchromium medication aspirin , clopidogrel bisulfate ( Plavix ISCOVER ) , ticlopidine ( Ticlid ) heparin . 10 . Concurrent medical condition life expectancy le 12 month ; 11 . Any major medical condition , Investigator 's opinion , may interfere optimal participation patient study ; 12 . Subject currently participate investigational drug another device study , include plan participation investigational drug another device study course present investigation ; 13 . Coronary angioplasty ( without stenting ) less 9 month index procedure site target vessel ; 14 . Previous coronary angioplasty ( without stenting ) time ( &gt; 9 month ) vessel segment le 5 mm proximal distal target lesion . 15 . Planned coronary angioplasty ( without stenting ) first 12 month index procedure segment target vessel ; 4.3 . ANGIOGRAPHIC EXCLUSION CRITERIA 1 . Restenotic target lesion ; 2 . More one lesion require treatment vessel ; 3 . Target vessel diameter &lt; 2.5 mm &gt; 3.5 mm ( visual estimation ) ; 4 . Long target lesion amenable treatment ( coverage ) 1619mm long stent ; 5 . Unprotected coronary artery branch lesion ( ≥50 % diameter stenosis ) 6 . Target lesion locate surgical bypass graft ; 7 . Total vessel occlusion ( TIMI flow grade 01 ) ; 8 . Target lesion ostial location ; 9 . Target lesion locate lateral branch bifurcation &gt; 2.5mm require lateral branch stenting ; 10 . Calcified target lesion anticipate unsuccessful/impracticable predilation ; 11 . Target vessel excessive tortuosity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>coronary artery</keyword>
	<keyword>thrombosis</keyword>
	<keyword>stent</keyword>
</DOC>